Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 8INDUSTRY 4NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Genitourinary 10Lymphoid 5Tumor-Agnostic 4Breast 4Thoracic 2Other solid neoplasm 1Gastrointestinal 1Dermatologic 1

Conditions

Neoplasms 3Carcinoma, Squamous Cell 1Carcinoma 1Adenocarcinoma 1

Interventions

pembrolizumab 62Paclitaxel 51Gemcitabine 50Carboplatin 45Docetaxel 43Cisplatin 31Pemetrexed 30Nivolumab 28Bevacizumab 28atezolizumab 22Fluorouracil 22Cetuximab 21Capecitabine 21Irinotecan 20Leucovorin 19Afatinib 18Erlotinib Hydrochloride 15trametinib 14Trastuzumab 13Ipilimumab 13130-nm albumin-bound paclitaxel 13regorafenib 11olaparib 11Sorafenib 11Oxaliplatin 11Drug Therapy 11eribulin 10enzalutamide 10Midazolam 10Injections 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × temsirolimus × Tumor-Agnostic × Clear all
NCT00838539 2018-09-18

Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors

Puma Biotechnology, Inc.

Phase 1 Completed
63 enrolled 26 charts
Tumor-Agnostic

Neoplasms

NCT01378377 2018-07-30

Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus

EMD Serono

Phase 1 Terminated
33 enrolled 21 charts
Tumor-Agnostic

Neoplasms

NCT00106353 2013-02-08

Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors

Pfizer

Phase 1/2 Completed
71 enrolled 42 charts
Tumor-Agnostic

Adenocarcinoma, Neoplasms

NCT00195299 2007-12-27

Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck

Wyeth is now a wholly owned subsidiary of Pfizer

Completed
20 enrolled
Tumor-Agnostic

Carcinoma, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡